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E D I T O R I A L
Building a supportive framework for brain research in Ireland: 
Inaugural position paper of the Irish Brain Council
1 |  INTRODUCTION: THE IRISH 
BRAIN COUNCIL
The Irish Brain Council is an independent group of organ-
isations which have come together to influence and impact 
upon brain research in Ireland. The purpose of the Irish Brain 
Council is to promote and advocate for brain research in 
Ireland. It aims to harness the expertise and experience of its 
membership to provide a platform for public outreach, legis-
lative engagement and strategic partnership to foster a sup-
portive environment for brain research that ensures Ireland's 
competitiveness in this area going forward and enables the 
attraction, retention and development of research initiatives 
in the understanding and treatment of brain conditions. This 
first inaugural position paper by the Irish Brain Council aims 
to outline the challenges and opportunities for brain research 
in this country and call for a supportive infrastructure to at-
tract future investment, retain highly qualified personnel and 
ensure that research findings are effectively translated into 
better outcomes for people with brain conditions. Brain re-
search was the initial focus of the European Brain Council 
(EBC) when it was launched 15 years ago; since then, how-
ever, the EBC has expanded into many other areas such as 
prevention, education, the patient's journey etc. The EBC has 
therefore recently adopted an alternative term ‘brain health’ 
in place of ‘brain research’, which is more holistic and more 
representative of their broader remit. For the remainder of 
this paper, we will use the term ‘brain health and research’ 
to mirror the aims of the EBC in the goals of the Irish Brain 
Council.
The Irish Brain Council aims to be inclusive of all areas 
of brain health and research aimed at improving the qual-
ity of life for people living with brain conditions. The Irish 
Brain Council is a group of representative organisations 
with the overall aim of influencing the landscape of scien-
tific research into brain conditions in Ireland. The Irish Brain 
Council adopts a broad definition of brain health and research 
covering the spectrum from basic science and translational 
research through clinical research, clinical trials to health ser-
vice interventions and research into health systems aimed at 
improving treatment and responses to the needs of those with 
brain conditions.
The membership of the Irish Brain Council is currently 
constituted as follows:
• The Irish Institute of Clinical Neurosciences (IICN)
• Neuroscience Ireland (NI)
• FutureNeuro Research Centre
• Dementia Neurodegeneration Network of Ireland (DNNI; 
affiliate)
• The Neurological Alliance of Ireland (NAI)
• The Psychological Society of Ireland (PSI)
• The College of Psychiatrists of Ireland (CPI)
• The Irish Consultant Neurologists’ Association (ICNA).
Table 1 indicates the main academic institutions, research 
centres and networks involved in brain research in Ireland. 
Many of these are represented through the constituent organ-
isations that make up the Irish Brain Council. It is important 
to stress that the list below is not exhaustive but represents 
an indicator of the vibrant connectedness that is one of the 
strengths of brain research in Ireland. Additional national net-
works related to neuroscience research are listed in Table 2.
The Irish Brain Council is an affiliated member of the 
EBC.
The mission of the Irish Brain Council is to promote brain 
health and research to improve the quality of life of those liv-
ing with brain conditions. The Irish Brain Council will strive 
to work in partnership with other representative organisations 
to influence the research landscape in Ireland so that the 
needs of all stakeholders, including those living with brain 
conditions, are recognised and addressed.
The strategic goals of the Irish Brain Council are as 
follows:
• To promote a strong advocacy for investment in and sup-
port of the development of brain health and research in 
Ireland.
• To promote the development of an infrastructure for brain 
health and research in Ireland that ensures that the sector 
can attract, retain and develop high‐quality research initia-
tives and researchers.
• To ensure that the views of all stakeholders are reflected 
in the work of the Irish Brain Council, including those 
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living with brain conditions and patient representative 
organisations.
• To encourage the use of research findings to inform 
health policy, practice and services for people with brain 
conditions.
2 |  THE COST OF BRAIN DISEASE 
AND PROPORTIONAL INVESTMENT 
IN BRAIN HEALTH AND RESEARCH
In November 2015, the EBC produced a Consensus 
Statement on the Need to Expand Brain Research in 
Europe (Morris et al., 2016) (EBC Consensus Statement, 
2015). Brain disorders affect over 179 million individuals 
in Europe, impacting on one in three Europeans during 
their lifetime. The cost of brain disorders to the European 
economy and national health budgets is in the region of 
€800 billion per annum, representing 45% of the annual 
European health budget and similar to that of cancer, car-
diovascular disease and diabetes together (Olesen et al., 
2010) . Indeed, it is estimated that over 1.1 million people 
in Ireland are living with a brain condition and the eco-
nomic cost has been estimated at €3 billion per year. The 
societal cost of multiple sclerosis alone in Ireland was re-
cently estimated at €429 m per year (MS Society of Ireland, 
2015). As the field of medicine moves towards the preven-
tative care and early intervention, a similar shift should be 
reflected in the area of brain health; the potential economic 
and societal savings brought about by early detection and 
T A B L E  1  Existing neuroscience research institutions and networks in Ireland
Higher education 
institute Name of centre Research focus Other information/links
Trinity College Dublin Trinity College Institute of 
Neuroscience
All www.tcd.ie/neuroscience
Global Brain Health Institute Dementia https://psychology.tcd.ie/gbhi/
Academic Unit of Neurology NeurodegenerationEpilepsy 
Multiple Sclerosis
https://www.tcd.ie/medicine/neurology/
Multi‐Institutional 
(hosted at RCSI)
FutureNeuro Research Centre Epilepsy and motorneurone 
disease (ALS)
www.futureneurocentre.ie
Multi‐Institutional 
(hosted at NUI Galway)
CURAM Centre for Research 
in Medical Devices
Parkinson's disease http://www.curamdevices.ie/
Multi‐Institutional 
(hosted at UCC)
APC Microbiome Ireland Psychiatric disease, brain‐gut 
axis
http://apc.ucc.ie/
University College Cork Cork Neuroscience Centre All https://www.ucc.ie/en/cns/
Multi‐Institutional 
(hosted at UCC)
INFANT Research Centre Brain development, 
neurophysiology
www.infantcentre.ie
National University of 
Ireland, Galway
Galway Neuroscience Centre All http://ncbes.nuigalway.ie/research/
galway-neuroscience-centre/
NICOG (Centre for neuroim-
aging and cognitive 
genomics)
Neuroimaging http://www.nuigalway.ie/colleges-and-
schools/arts-social-sciences-and-celtic-
studies/psychology/research/
research-themes/brain-behaviour/nicog/
Centre for Pain Research Pain http://www.nuigalway.ie/
centre-for-pain-research/
Maynooth University NUIM Neurolab Cognitive neuroscience https://maynoothneurolab.wordpress.com/
ALL Institute Assisting living and learning https://www.maynoothuniversity.ie/
all-institute
Human Health Institute Human health https://www.maynoothuniversity.ie/
human-health-institute
Hamilton Institute Mathematics, computation https://www.maynoothuniversity.ie/hamilton
Dublin City University International Centre for 
Neurotherapeutics
Neurotherapeutics https://www.dcu.ie/icnt/index.shtml
INSIGHT Centre Data analytics http://www.insight-centre.org/
University College 
Dublin
UCD Centre for Neuroscience All http://www.ucd.ie/ucdneuro/
Conway Institute Neurobiology https://www.ucd.ie/conway/
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early intervention for brain diseases during critical peri-
ods of brain development far outweigh the financial costs 
of treatment. Such early interventions can fundamentally 
alter the trajectory of both disease and patient outcomes, 
thus preserving their capacity to effectively integrate into 
society.
While there are estimates of the prevalence of neurologi-
cal disease for some conditions in Ireland, and very accurate 
data for both incidence and prevalence of some rare condi-
tions (e.g. Motor Neurone Disease), there are insufficient 
accurate data at present to generate a meaningful cost of dis-
ease in terms of disease burden (to include diagnostic costs, 
management costs—including years of life lost, years lived 
with disability and disability‐adjusted life‐years lost). The es-
timate is therefore based on an extrapolation from other coun-
tries. Clearly more work needs to be done in this area and the 
data cited in this paper are intended to be representative of 
the overall situation rather than the outcome of a systematic 
approach to the cost of brain conditions in Ireland.
Research investment in the neurosciences/brain research 
remains behind cancer and cardiovascular research and there 
is currently no directly targeted funding for neuroscience 
research. The Irish Brain Council carried out a survey of 
research funding income for neuroscience‐related projects 
in 2017 across the seven Irish universities, yielding a total 
investment in 2017 of €22,663,108 (please note: data from 
Trinity College Dublin were unavailable at the time of writ-
ing and are therefore not included). This figure includes proj-
ects addressing brain health as well as brain disease; it proved 
to be impossible to disentangle research funding for brain 
health from that addressing brain disease/disorder, as most 
(if not all) projects address some aspect of each.
2.1 | The Irish Brain Council supports the 
call outlined in the European Brain Council 
Consensus Statement (2015)
It is imperative to improve the prevention, treatment and 
management of brain disorders for humanitarian, scientific, 
societal, political and economic reasons:
• We call on all European authorities to devise and implement a 
plan to tackle brain health in an integrated and comprehensive 
manner in cooperation with all the EU member states
• We highlight the need to augment the support for basic 
and clinical brain research in Europe through current 
funding platforms, especially to retain promising young 
neuroscientists
• We recommend the EBC serve as a liaison to optimise sup-
port for patients and research and to ensure funding sup-
port is best aligned with today's fundamental challenges 
and opportunities
• We recognise that it is the joint responsibility of all stake-
holders to ensure that basic research is adequately trans-
lated into concrete applications
• Only by maintaining brain science high on the political 
agenda can both basic and clinical research be fortified 
and the burden of brain diseases reduced, preventing them 
from becoming a social emergency.
2.2 | Advocacy in relation to the consensus 
statement: EBC & Irish Brain Council
A key recommendation made in the Consensus Statement 
is that neuroscience must receive more political attention as 
T A B L E  2  Other neuroscience‐related networks in Ireland
Type of network Name Research focus Other information/links
Multi‐institutional Dementia and 
Neurodegeneration 
Network Ireland
Research focus is neurodegenerative disease 
including:ó
• Dementia (including Alzheimer's disease)
• Parkinson's disease (PD)
• Motor neurone diseases (MND)
• Huntington's disease (HD)
• Prion disease
• Spinocerebellar ataxia (SCA)
• Spinal muscular atrophy (SMA)
http://www.dementia-neurodegeneration.
ie/
Multi‐institutional Neuroscience Ireland General https://neuroscienceireland.com/
Multi‐institutional Irish Institute of Clinical 
Neuroscience (IICN)
Clinical neuroscience http://www.iicn.ie/
The Neurological 
Alliance of Ireland 
(NAI)
Neurological conditions https://www.nai.ie/
The Medical Research 
Charities Group 
(MRCG)
General https://www.mrcg.ie/
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well as the largest part of the European budget for medical 
research. In view of this, the EBC has made a strong case for 
increasing the budget of the next EU Framework Programme 
that will fund research and innovation during 2021–2027 
entitled ‘Horizon Europe’ and for making more funding 
available for health research. In 2018, the EBC launched 
a position statement ‘Counting Down to Zero’ (European 
Brain Council, 2018) which calls on the EU institutions to 
increase the Horizon Europe budget to at least €120 billion 
and significantly increase the budget of the ‘health’ cluster 
under Pillar II. This statement has been endorsed by over 30 
healthcare stakeholders across disciplines and disease areas. 
The EBC also wrote to EU ministers responsible for research 
prior to the Competitiveness Council meeting in July 2017, 
calling on them to increase the Horizon Europe budget. The 
EBC also provided input to a call for feedback that was 
launched by the European Commission in the summer of 
2018 and highlighted the need for a robust Horizon Europe 
programme. European Brain Council also underlined that 
further specific objectives aimed at supporting brain research 
should be included in the programme. During the weeks after 
the consultation, six national brain councils wrote to their na-
tional governments and called for a budget increase.
The consensus statement underlines that there is a clar-
ion call for greater ‘translational’ potential of basic science. 
Against this backdrop, the EBC organised a session on ‘the 
Value of Innovation’ as part of the event ‘Brain Research 
in Europe’ on 25th April 2017. A wide range of healthcare 
stakeholders (patient representatives, payors, brain research-
ers, industries, etc.) exchanged views on issues that affect 
innovation and how breakthroughs can be translated into tan-
gible solutions for patients.
The Irish Brain Council organises an annual meeting to 
showcase innovation in brain research taking place in Ireland, 
and also to promote and reiterate the messages of the con-
sensus statement within an Irish context. Since the launch of 
the consensus statement in 2016, the focus of the Irish Brain 
Council has been on developing the umbrella in order that it 
is in a stronger position to be an advocate for brain research 
in Ireland.
3 |  IRISH BRAIN COUNCIL 
INAUGURAL POSITION PAPER
The factors impacting on the strength and sustainability of 
brain health and research in Ireland are reflected across the 
research landscape and require systemic change. Brain health 
and research is an area of emerging opportunity in Ireland, 
but the sector is affected by significant challenges which im-
pact on the entire research landscape. This inaugural position 
paper from the Irish Brain Council highlights the critical is-
sues facing brain health and research in Ireland. The paper 
also puts forward a series of recommendations to address 
these challenges:
The main recommendations focus on the following:
1. The importance of overall leadership and direction in 
relation to clinical research in Ireland
2. The importance of sustainable funding for brain health 
and research, across the full continuum from basic neuro-
science to clinical research
3. The importance of networks and career pathways to sup-
port researchers
4. The importance of developing the infrastructure to sup-
port brain health and research
5. The need to involve patients and patient organisations as 
key stakeholders
6. Legislative and policy development and implementation 
to support brain health and research
3.1 | The importance of overall 
leadership and direction in relation to clinical 
research in Ireland
There is a critical need for a clear vision and strategy for 
clinical research in Ireland. The current landscape for clini-
cal and biomedical research in Ireland is fragmented with a 
lack of leadership at national level to support research and 
translate the findings into improved patient care and practice 
within the health services. The Irish Academy of Medical 
Sciences’ Position Paper (2012), ‘A framework for Irish 
clinical research in the 21st century’, points out the value of 
the UK National Clinical Research Institute in providing a 
coherent approach across the health system in relation to re-
search. The NIHR plays a key role in promoting career tracks 
and training for clinical scientists, developing the informa-
tion technology necessary to support high‐quality clinical 
research and, importantly, identifying specific research areas 
for prioritisation and development.
The NIHR represents a suitable template for supporting 
clinical research into brain conditions in Ireland. The struc-
ture of Irish healthcare is similar to the UK, in that most 
care is funded directly from the exchequer through a Health 
Services Executive, rather than through a system of private 
medicine‐ or insurance‐based funding. The acute hospitals 
within the public sector are grouped around academic centres 
with a Group CEO, and each Hospital Group has a nominated 
Chief Academic Officer. This existing structure aligns well 
with a proposed NIHR structure, in which clinical research 
funding is channelled through the academic and clinical 
facilities.
The Irish Brain Council endorses the need for a focused 
strategy and vision for clinical research in Ireland led by the 
Department of Health and addressing key areas of legislative 
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support, funding and infrastructure to support research. The 
Brain Council welcomes the appointment in 2017 of a Head 
of Research and Development and Health Analytics in the 
Department of Health which provides an important focus for 
leadership within this area in the health services. The Irish 
Brain Council advocates for an Irish Institute for Health 
Research to integrate hospital‐ and academic‐based research.
3.2 | The importance of sustainable funding 
for brain health and research
Sustained public funding for brain health and research is 
critical to develop vital infrastructure and attract private and 
international investment. Funding challenges for brain health 
and research in Ireland include an overall disproportionately 
low allocation of the research spend across Europe, including 
Ireland, to brain disease in comparison to other disease areas. 
Other issues include the challenge of attracting international 
research funding to Ireland and ongoing threats to funding for 
basic neuroscience research.
Low levels of public investment continue to impact on 
the infrastructure for engaging in translational, clinically 
applied and population‐based research into brain condi-
tions in Ireland and impact on this country's overall com-
petitiveness in an area where we can provide international 
leadership. The strategic decision to prioritise applied/
translational research at the expense of basic/fundamen-
tal science and to prioritise a limited number of research 
areas, has proven particularly detrimental to brain health 
and research in Ireland, as shown by disproportionately low 
funding awarded to brain health and research activities (see 
above), and constant calls for a change in policy from senior 
academics in Ireland and beyond. Basic scientific research 
has been shown in other countries to generate a substantially 
greater economic return over the long term, and an active 
system of basic research provides the essential expertise, 
training and absorptive capacity to enable development and 
adoption of new technologies and translational opportuni-
ties. The Irish Brain Council supports the need for greater 
overall public investment in biomedical research in Ireland 
as well as the requirement to target some of this investment 
to brain disease areas.
3.2.1 | Case example: Lack of neuroimaging 
infrastructure to support brain research 
in Ireland
Ireland is relatively unique in comparison with other first 
world countries in the relative paucity of clinical research 
infrastructure for neurological research. Neuroimaging 
provides a useful example. There is only one dedicated 3T 
Research MRI scanner available which operates on a com-
mercial basis, and no research PET facilities. As no public 
facility in Ireland has a cyclotron, it is impossible to conduct 
any PET imaging that requires labelled ligands with a short 
half‐life.
A number of clinical research facilities are linked to pub-
lic hospitals, but these are stand‐alone units and operate at 
commercial rates. Because of this, the collection of biologi-
cal samples such as CSF and fibroblasts for biobanking pur-
poses is logistically challenging in a clinical setting, as there 
are no dedicated facilities or staff. This is in part a function of 
the very low numbers of academic clinicians with protected 
research time within the Irish health system. Finally, there is 
a small Brain Bank in operation, but there is no sustainable 
ongoing funding to support this, and public awareness of the 
facility is low.
3.3 | The importance of networks and 
career pathways to support researchers
Developing networks and establishing appropriate career 
pathways to support researchers are crucial in strength-
ening and retaining research capacity in relation to brain 
health and research in Ireland. Support for networks 
both within and between disciplines in brain health and 
research is crucial. The creation of economies of scale 
in accessing emerging technologies, ensuring competi-
tiveness, attracting international research and providing 
training and information through the network structure 
is of vital importance. Development of coherent research 
networks through an Institute of Health Research can 
promote greater interaction between laboratory‐based 
research, hospital research and industry are particularly 
important in the context of advancing understanding of 
the brain and development of new treatments. Such an ap-
proach could also address the current limitation of career 
opportunities for Irish researchers. Challenges includ-
ing short‐term contracts and funding restrictions impact 
greatly on the training at undergraduate and postgraduate 
levels. These problems are further compounded by the ab-
sence of career tracks for clinical academic researchers, 
and make Ireland increasingly unattractive for ambitious 
and competitive researchers. The Irish Health Research 
Forum (2016) recognised these concerns and has outlined 
how best to address the very serious problem of emigra-
tion of our best researchers. The Irish Brain Council calls 
for a national strategic approach to academic and clini-
cal research, integrated by a National Institute for Health 
Research. The Brian Council calls for the prioritisation of 
career pathways in the neurosciences, and the provision of 
core infrastructure that will enable our best neuroscience 
researchers to remain in Ireland, and which will encourage 
and provide for structured engagement between academ-
ics, hospital‐based stakeholders and potential industrial 
partners.
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3.4 | The importance of 
developing the infrastructure to support brain 
health and research
Investment in and development of new technologies and in-
formation systems to support brain health and research are 
vital to capitalise on niche areas where Ireland can be a leader 
in brain health and research. Ireland's size presents specific 
challenges around attracting research and engaging in col-
laboration with international partners. However, Ireland ex-
cels as a centre for population‐based research. Because of its 
size, island status and genetic substructure, Ireland is ideally 
suited to population‐based studies of complex genetic con-
ditions, for example velocardiofacial syndrome (VCFS) and 
cystinosis. Irish researchers have already made significant 
international contributions in neuroepidemiology, deep phe-
notyping, population genetics and care pathways. It is impor-
tant to recognise the significant return on investment that can 
be provided to Ireland through the development of research 
infrastructure in brain health and research.
However, there remains a critical need to develop the sup-
portive infrastructure that will allow Ireland to capitalise on 
its important niche in these areas. The development of unique 
patient identifiers, electronic patient records, support for 
population‐based registers that collect data from all patients, 
and access to emerging technologies including advanced neu-
roimaging, and functional tools for gene manipulation will 
be essential to remain competitive. The Irish Brain Council 
calls for the recognition of Ireland as a country ideally suited 
to population‐based research in brain disorders, by provid-
ing adequate infrastructure and resources to enable detailed 
subphenotyping of those consenting to participate in research 
programmes. This would be best achieved by integration of 
epidemiology, clinical evaluation and genomics work through 
a National Institute for Health Research.
3.5 | The need to involve patients and 
patient organisations as key stakeholders in 
brain health and research
Patient involvement is a key to informing and improving 
brain health and research while patient organisations rep-
resent a vital link between patients, researchers and policy 
makers. Patient involvement describes a variety of ways 
in which researchers engage with people for whom their 
research holds relevance. There is a growing body of evi-
dence that involving patients in research projects improves 
the quality, relevance and/or speed of that research. It is 
important that patients are facilitated to become involved 
at all stages of the research process so that they inform 
research questions, have input into the design of research 
protocols and play an active role in translating findings 
into practice (EU Parliament Interest Group on Brain Mind 
and Pain, 2014). Patient organisations play a critical role 
in promoting and supporting the involvement of patients 
in research. Patient organisations in Ireland currently pro-
vide significant financial support to fund medical research 
through providing specific research funding awards and 
fundraising for specific projects.
Patient organisations are also involved in informing their 
members about current opportunities for becoming involved 
in research studies, an invaluable support for recruiting par-
ticipants. Patient organisations provide a critical conduit for 
linking patients to researchers, both in terms of recruiting 
participants and in communicating research findings. Patient 
organisations have a central role in ensuring that research 
findings are translated into practice through their engagement 
with policy makers and advocating on behalf of the people 
they represent. Most importantly, patient organisations pro-
mote a positive image of brain health and research and the 
value of taking part in research studies in Ireland that should 
not be underestimated.
A report by the Neurological Alliance of Ireland (2015) 
found a strong commitment to supporting research among 
neurological not for profit organisations, including providing 
direct funding support for research and engaging in ongoing 
partnerships with individual researchers and research insti-
tutions to support participation in research and the dissem-
ination and implementation of research findings. The Irish 
Brain Council is committed to promoting the involvement of 
patients in all stages of research and working in partnership 
with patient organisations as a key linkage between patients, 
researchers and policy makers.
Table 3 highlights a range of patient organisations provid-
ing crucial support for research into neurological conditions 
in Ireland.
3.6 | Legislative and policy 
development and implementation to support 
brain health and research
Legislative change, policy implementation and overall lead-
ership are required to support and develop brain health and 
research in Ireland. Important legislative developments are 
required to support research into brain conditions in Ireland 
and provide important assurance for members of the public 
in areas such as oversight and ethics, data protection, the use 
of human tissue etc.
In 2017, the Department of Health in Ireland launched a 
public consultation to develop a national Health Information 
Policy (Submission to the Department of Health's Public 
Consultation on a New National Health Information Policy, 
2017) . The comment below by HIQA (Health information 
and Quality Authority) is a good summary of the challenges 
faced by Ireland in this area and the requirement for appropri-
ate legislation and policy to address the current shortcomings:
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Ireland needs to develop strong health infor-
mation policies and legislation to advance the 
eHealth agenda and to support, for example, 
the introduction of electronic health records. 
Ireland's health information landscape is cur-
rently highly fragmented and legislation is vital 
to ensure that valuable information is accessed, 
shared and governed appropriately and that 
an individual's personal health information is 
protected.
The Department of Health in Ireland also carried out 
a public consultation in 2017 on proposals for a Human 
Tissue Bill. Progressing these areas of legislation will be a 
T A B L E  3  Support for brain research among Irish neurological patient organisations
Patient organisation Support for research
Progressive Supranuclear Palsy Association of Ireland 
(PSPA Ireland) 
www.pspaireland.ie
The organisation established a dedicated research fund in 2017 to support research 
into Progressive Supranuclear Palsy (PSP) and Corticobasal Degeneration (CBD)
The organisation aims to improve the opportunity for their membership to take part 
in research and trials here in Ireland, to engage with researchers to get a better 
understanding of the status of this condition in Ireland, to advance knowledge in 
these progressive conditions which will hopefully lead to finding a treatment or a 
cure
Migraine Association of Ireland 
www.migraine.ie
The organisation supports researchers in the design, recruitment and dissemination of 
research findings into migraine and quality of life of migraine sufferers both in 
Ireland and internationally
Multiple Sclerosis Society of Ireland 
www.ms-society.ie
Research is one of five Strategic Priority areas in MS Ireland's Strategic Plan for the 
period 2015–2019. The organisation also has a dedicated research strategy and 
research committee
Headway Ireland 
www.headway.ie
Headway supports people with Acquired Brain Injury to live in the community 
through a range of rehabilitative services. Research has always been undertaken 
within the organisation both as a means of ensuring we adopt evidence‐based 
practice but also as way to contribute to the field of rehabilitation studies. Current 
projects include a collaborative study to establish the epidemiology of Traumatic 
Brain Injury in Ireland, a study on the mental health impact of aphasia, therapeutic 
filmmaking and qualitative research on service interventions, amongst others
Epilepsy Ireland 
www.epilepsy.ie
Supporting Irish epilepsy research is a key strategic objective of Epilepsy Ireland. 
Since 2010, over €1 m has been invested in a variety of projects across basic 
science, genetics, health services, epilepsy deaths and psychosocial aspects of 
epilepsy. In 2017, new funding was provided for a study on ketogenic diet biomark-
ers, while projects on the impact of epilepsy specialist nurses and on epilepsy 
disclosure were completed. Epilepsy Ireland also continues to fund the Irish 
Epilepsy Deaths Register and is actively collaborating with research partners on 
studies on patient centred care, PPI, e‐health development and valproate risk 
minimisation. The organisation also focuses on communicating to patients both the 
latest research developments and opportunities to volunteer in ongoing studies
Acquired Brain Injury Ireland 
www.abiireland.ie
Acquired Brain Injury Ireland is strategically committed to supporting research that 
generates an evidence base and advances knowledge and understanding to inform 
service developments, ensure best practice and engage in effective policy advocacy. 
It does so in a range of ways including funding external research, engaging in 
research internally, directly commissioning research to inform policy development 
and facilitating, where appropriate, the active participation of people using our 
services and their families in research projects. It also hosts an annual seminar for 
clinicians to showcase brain injury research in Ireland and uses national and 
international events to share and disseminate research
Alzheimer Society of Ireland 
www.alzheimer.ie
The Alzheimer Society of Ireland has developed a research strategy (2017–2020). 
The strategy sets out a plan to amplify the voice of the person with dementia and 
carers by developing and implementing PPI strategies. The research strategy also 
acknowledges the various gaps in knowledge and understanding of dementia, and 
plans to address these research gaps through avenues, such as a PhD scholarship 
programme. The ASI aim to increase their research budget over the coming years
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key to improving the regulatory framework in Ireland going 
forward.
The European Data Protection Directive replaced the 
1995 Data Protection Directive and came into force in 
Ireland in May 2018. The implications for research are still 
uncertain with legislation due to be introduced early in 
2019. The Irish Brain Council will monitor these develop-
ments closely, given the implications for patient‐oriented 
research.
4 |  CONCLUSION
Our recommendations can be summarised as follows (see 
Box 1).
There is a vital need to invest in brain disorders. This 
should include the funding of career paths for laboratory‐
based neuroscientists while at the same time implement-
ing programmes for clinician scientists. These researchers 
must be facilitated in the development of bench to bedside 
research, and in the provision of evidence‐based models 
of care for neurology and neuro‐rehabilitation within the 
health services. This would be best achieved through the 
development of managed clinical networks that are ex-
tensively networked with academic centres of excellence 
engaged in neuroscience research, and with access to infor-
mation technology and the provision of opportunities for 
ongoing training and development of staff. The Irish Brain 
Council calls for leadership at a national level to drive a 
focused agenda around brain health and research that pro-
vides critical overall strategic direction in relation to all 
aspects of research within the health services.
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Box 1 Summary of recommendations by the Irish 
Brain Council
The IBC calls for the following actions
Political focus on brain health and research—legislative and 
policy development/implementation
Facilities to maintain a Brain Bank
Funding for training/career pathways for researchers
Infrastructure for maintaining talent in Ireland/attracting talent 
back—including neuroimaging infrastructure
Infrastructure to facilitate translational, bench to bedside 
treatments—medical centre/academic centre
Developing/maintaining a system for electronic medical 
records
Sustainable, targeted funding opportunities
Working with patient organisations to engage patients at all 
stages of research
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